UK Report Highlights Call for More Inclusive and Accessible Medicines Research and Care
A new UK report calls for more inclusive, accessible medicines research and healthcare practices, highlighting stakeholder insights on improving the entire medicines lifecycle from discovery to use.
A comprehensive new report released in the UK on June 23, 2025, underscores the urgent need to make medicines research and healthcare more inclusive and accessible for all. Led by researchers from the University of Liverpool, Manchester Metropolitan University, and University College London, the study engaged both the public and healthcare professionals through workshops and discussions to gather diverse perspectives on the entire lifecycle of medicines, from discovery to everyday use.
The report, titled "Better Medicines: Public and Professional Views on the Lifecycle from Discovery to Taking Medicines," reflects a wide range of insights across the healthcare and life sciences sectors, including experiences of patients, clinicians, researchers, industry experts, and regulators. It emphasizes that while there is widespread trust in the scientific advancements and safety processes, there are notable gaps and opportunities for improvement.
Key findings reveal that both the public and professionals agree on the significant positive impact of medicines on health outcomes and express admiration for the UK's publicly funded healthcare system. However, they also identify disparities and areas needing attention, such as reaching underrepresented groups, addressing regional inequalities, and tackling systemic barriers in research.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Bone Metastases and Immune Archetypes Unveiled by Single-Cell RNA Sequencing
A recent study uncovers three distinct immune archetypes within bone metastases from multiple cancer types using single-cell RNA sequencing, highlighting the heterogeneity and potential for tailored therapies.
Innovative Dual-Target CAR-T Cells Show Promise Against T-ALL Leukemia in Preclinical Studies
New dual-target CAR-T cell therapy shows promising preclinical results against T-ALL leukemia by targeting unique markers, paving the way for more effective treatments.
Targeting Mitochondrial Protein VDAC2 Could Enhance Liver Cancer Treatments
Researchers have identified VDAC2, a mitochondrial protein, as a promising target to enhance selective liver cancer treatments, potentially improving patient outcomes with targeted therapy.
Breakthrough Genetic Research Spurs Large-Scale Diabetes Trials in Chinese Hospitals
A groundbreaking genetic study in China has led to the development of a new diagnostic tool for more accurate classification of diabetes types, paving the way for large-scale clinical trials and personalized treatment approaches.